Kate joined the CTTC team in October 2025 to provide FDA regulatory guidance to Vanderbilt researchers developing and investigating medical devices. She began working at Vanderbilt University Medical Center (VUMC) in 2004 and has contributed to clinical research across several departments, including the Vanderbilt-Ingram Cancer Center, Pediatrics, and Otolaryngology. Since 2010, she has led research operations in Otolaryngology, coordinating investigator-initiated, NIH-funded, and industry-sponsored clinical trials, many involving FDA-regulated drugs and devices.
She has successfully guided teams through multiple FDA and IRB audits and secured FDA investigational device exemption approvals for two surgical projects. In 2016, Kate earned a Master of Jurisprudence in Health Law from Loyola University, enhancing her expertise in regulatory affairs and medical product development.